tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IMNM Stock Latest News

Immunome Announces Follow-On Public Offering Pricing
Company AnnouncementsImmunome Announces Follow-On Public Offering Pricing
23d ago
8K
IMNM
Midday Fly By: Warner Bros. urges investors to reject Paramount bid
PremiumThe Fly
Midday Fly By: Warner Bros. urges investors to reject Paramount bid
23d ago
PG
ABM
Immunome falls -7.2%
PremiumThe Fly
Immunome falls -7.2%
23d ago
IMNM
Immunome 18.625M share Spot Secondary priced at $21.50
PremiumThe Fly
Immunome 18.625M share Spot Secondary priced at $21.50
24d ago
IMNM
Immunome price target raised to $32 from $22 at Lake Street
PremiumThe Fly
Immunome price target raised to $32 from $22 at Lake Street
24d ago
IMNM
Immunome price target raised to $40 from $18 at Evercore ISI
PremiumThe FlyImmunome price target raised to $40 from $18 at Evercore ISI
24d ago
IMNM
Immunome price target raised to $35 from $25 at Guggenheim
Premium
The Fly
Immunome price target raised to $35 from $25 at Guggenheim
24d ago
IMNM
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
25d ago
IMNM
KYTX
Immunome offers to sell $400M in common stock
PremiumThe Fly
Immunome offers to sell $400M in common stock
25d ago
IMNM
Immunome’s Promising Outlook: Buy Rating Affirmed on Varegacestat’s Phase 3 Success and Strong Management
PremiumRatings
Immunome’s Promising Outlook: Buy Rating Affirmed on Varegacestat’s Phase 3 Success and Strong Management
25d ago
IMNM
Immunome price target raised to $40 from $38 at Leerink
PremiumThe Fly
Immunome price target raised to $40 from $38 at Leerink
25d ago
IMNM
Midday Fly By: Intel eyes SambaNova, Cencora to acquire OneOncology
PremiumThe Fly
Midday Fly By: Intel eyes SambaNova, Cencora to acquire OneOncology
25d ago
KO
COR
Here’s Why Immunome Stock (IMNM) Soared Over 20% Today
PremiumMarket NewsHere’s Why Immunome Stock (IMNM) Soared Over 20% Today
25d ago
IMNM
Immunome’s Varegacestat Shines in Phase 3 RINGSIDE Trial, Earning Buy Rating from Charles Zhu
Premium
Ratings
Immunome’s Varegacestat Shines in Phase 3 RINGSIDE Trial, Earning Buy Rating from Charles Zhu
25d ago
IMNM
Immunome up 34% in pre-market at $26.25 after varegacestat Phase 3 data
Premium
The Fly
Immunome up 34% in pre-market at $26.25 after varegacestat Phase 3 data
25d ago
IMNM
Immunome reports RINGSIDE trial met primary, secondary endpoints
PremiumThe Fly
Immunome reports RINGSIDE trial met primary, secondary endpoints
25d ago
IMNM
Immunome Announces Positive Phase 3 Trial Results
PremiumCompany Announcements
Immunome Announces Positive Phase 3 Trial Results
25d ago
8K
IMNM
Immunome initiated with a Buy at Truist
PremiumThe Fly
Immunome initiated with a Buy at Truist
1M ago
IMNM
Immunome price target raised to $33 from $25 at Stephens
PremiumThe Fly
Immunome price target raised to $33 from $25 at Stephens
2M ago
IMNM
Immunome’s Strategic Clinical Advancements and Financial Alignment Justify Buy Rating
PremiumRatingsImmunome’s Strategic Clinical Advancements and Financial Alignment Justify Buy Rating
2M ago
IMNM
Immunome, Inc. Reports Q3 2025 Financial Results
Premium
Company Announcements
Immunome, Inc. Reports Q3 2025 Financial Results
2M ago
IMNM
Immunome’s Strategic Advances and Promising Pipeline Justify Buy Rating
Premium
Ratings
Immunome’s Strategic Advances and Promising Pipeline Justify Buy Rating
2M ago
IMNM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >